Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. Recommends Tighter Control on Hydrocodone Pain Pills
Bloomberg
Friday, October 25, 2013 - 10:04am
tags:
hydrocodone, Zohydro, Zogenix, FDA
Partnerships Have Been a Boost for Inovio
Motley Fool
Friday, October 25, 2013 - 9:59am
tags:
Inovio, Roche
BioMarin Pharma Q3 Net Loss Deepens, Revenue Rises
Motley Fool
Friday, October 25, 2013 - 9:58am
tags:
earnings, Biomarin
Pfizer Leads Jump in Pharmaceutical Lobbying
Roll Call
Friday, October 25, 2013 - 9:57am
tags:
lobbying, Pfizer
Eisai Loses Lawsuit Against DEA Over Scheduling Epilepsy Pill
Pharmalot
Friday, October 25, 2013 - 9:55am
tags:
Eisai, DEA, epilepsy, Fycompa
Novartis' Pharmaceutical Business Faces 2 Major Challenges
Motley Fool
Friday, October 25, 2013 - 9:41am
tags:
Novartis, Gilenya, Tecfidera, GSK, Seebri Breezhaler, COPD, Xolair
AbbVie Profit Beats Estimates as Sales of Humira Increase
Bloomberg
Friday, October 25, 2013 - 9:39am
tags:
earnings, AbbVie
ImmunoGen narrows fiscal 1Q loss to $11.2 million
Yahoo/AP
Friday, October 25, 2013 - 9:37am
tags:
Immunogen, earnings
Earnings Preview: Merck to report 3Q results
Yahoo/AP
Thursday, October 24, 2013 - 6:06pm
tags:
Merck, earnings
J&J-Medivir Hepatitis C Pills Wins U.S. Panel Backing
Bloomberg
Thursday, October 24, 2013 - 6:04pm
tags:
FDA, JNJ, Medivir, hepatitis C, simeprevir
An FDA Panel Chair Talks To Industry Insiders About FDA Panels
Pharmalot
Thursday, October 24, 2013 - 12:15pm
tags:
FDA, advisory panels
Diabetes Giants Battle Outside of Their Usual Arena
Motley Fool
Thursday, October 24, 2013 - 11:29am
tags:
Novo Nordisk, diabetes, Merck, Sanofi, NovoSeven, JNJ
2 Big Problems for GlaxoSmithKline
Motley Fool
Thursday, October 24, 2013 - 11:28am
tags:
GSK, China, Advair
FDA Approves First New Atherectomy Device In 20 Years
Forbes
Thursday, October 24, 2013 - 10:31am
tags:
FDA, atherectomy, devices, Diamondback 360, Cardiovascular Systems
FDA Grants Lilly's Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
Marketwatch
Thursday, October 24, 2013 - 10:29am
tags:
FDA, ramucirumab, Eli Lilly, gastric cancer
Teva ex-chairman: Execs should share layoffs pain with 10% pay cut
Fierce Pharma
Thursday, October 24, 2013 - 10:27am
tags:
executive pay, Teva, layoffs
Repros plummets as FDA questions testosterone drug data
Fierce Biotech
Thursday, October 24, 2013 - 10:26am
tags:
FDA, Repros Therapeutics, testosterone, Androxal
Zimmer slides on Q3 profit slide, narrowed guidance
Mass Device
Thursday, October 24, 2013 - 10:24am
tags:
Zimmer, earnings, devices
Bristol-Myers Squibb - There Is Life After Plavix
Seeking Alpha
Thursday, October 24, 2013 - 10:19am
tags:
Plavix, Bristol-Myers Squibb, JNJ, PFE
Mead Johnson profit rises as volumes grow in China, Hong Kong
Reuters
Thursday, October 24, 2013 - 10:18am
tags:
earnings, China, Hong Kong, Mead Johnson

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.